哮喘
医学
表皮生长因子受体
发病机制
病态的
表皮生长因子
表皮生长因子受体抑制剂
免疫学
生物信息学
受体
病理
内科学
生物
作者
Ye Liu,Pengfei Li,Tianci Jiang,Yue Li,Yu Wang,Zhe Cheng
标识
DOI:10.1016/j.rmed.2023.107117
摘要
Activation of the epidermal growth factor receptor (EGFR) pathway is involved in the pathogenesis of asthma. Although decades of intensive research have focused on the role of EGFR in asthma, the specific mechanisms and pathways of EGFR signaling remain unclear. Various reports have indicated that inhibition of EGFR improves the pathological features in asthma models. However, extending these experimental findings to clinical applications is difficult. Several measures can be adopted to promote clinical application of EGFR inhibitors. This review focuses on the role of EGFR in the pathogenesis of asthma and the development of a potentially novel therapeutic target for asthma.
科研通智能强力驱动
Strongly Powered by AbleSci AI